Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in August
August 04 2022 - 4:01PM
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage
biopharmaceutical company dedicated to the research, development
and commercialization of innovative therapies for rare diseases of
the eye, today announced that management will participate in the
following virtual healthcare investor conferences in August 2022:
2022 Wedbush PacGrow Healthcare ConferenceDate:
Wednesday, August 10, 2022Company management will participate in a
fireside chat at 8:00 a.m. ET.
H.C. Wainwright & Co. 2nd
Annual Ophthalmology Virtual ConferenceDate:
Wednesday, August 17, 2022A pre-recorded presentation will be made
available beginning Wednesday, August 17, 2022 at 7:00 a.m. ET.
To access the webcasts and subsequent archived recordings of the
fireside chat and podium presentation, please visit the
“Presentations” section of the Kala website at
http://kalarx.com.
About Kala Pharmaceuticals, Inc.
Kala is a clinical-stage biopharmaceutical company dedicated to
the research, development and commercialization of innovative
therapies for rare diseases of the eye. Kala’s biologics-based
investigational therapies utilize Kala’s proprietary Mesenchymal
Stem Cell Secretome (MSC-S) platform. Kala’s lead product
candidate, KPI-012, is in clinical development for the treatment of
persistent corneal epithelial defect (PCED), a rare disease of
impaired corneal healing, which has received orphan drug
designation from the U.S. Food and Drug Administration. Kala is
also targeting KPI-012 for the treatment of Partial Limbal Stem
Cell Deficiency and ocular manifestations of moderate-to-severe
Sjögren's and plans to initiate preclinical studies to evaluate the
utility of its MSC-S platform for retinal degenerative diseases,
such as Retinitis Pigmentosa and Stargardt Disease. For more
information on Kala, please visit www.kalarx.com.
Investor Contact:
Hannah Deresiewiczhannah.deresiewicz@sternir.com
212-362-1200
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From May 2024 to Jun 2024
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Jun 2023 to Jun 2024